Fierce Biotech Mix Logo.png Fierce Biotech Mix Logo.png
Webinar

The Hidden Risk in Early Development: Why Programs Lose Momentum

Available on-demand
60 Minutes

Understanding the Value of Continuity.

Early phase development is a continuous journey from First-in-Human (FIH) to Proof-of-Concept (PoC). Yet frequent team and leadership transitions can create risk, slow decisions and dilute critical knowledge just as programs grow more complex and valuable.

Join us for this valuable session to explore why continuity across project leadership, monitoring, and execution teams is a strategic advantage for early phase success.

Learn about:

  • How consistency improves decision quality and scalability
  • Why institutional knowledge is a critical asset in adaptive early phase programs
  • Key operational and scientific risks introduced by team handoffs
  • The impact continuous leadership has on influencing protocol evolution and development confidence 
  • What effective early phase program ownership looks like beyond a CPU
  • And more

Speakers

DrVince-HS-Beth-9112024.png

Beth Williams

Beth Williams, Executive Director of Clinical Trial Services, has worked in the pharmaceutical industry for more than 13 years. Her leadership role is rooted in practical experiences developed as a project manager. Beth is responsible for key project activities including the operational conduct of studies, coordination of vendors and client communication. Beth maintains high quality, scientific and ethical standards while ensuring timely management of the study from protocol inception to CSR finalization.

Chris Hardage hs.png

Chris Hardage

Chris Hardage has over 25 years of clinical research experience with an emphasis on early clinical development and Phase 1 studies for over 20 years. His industry experience includes clinical trial coordination, project management, clinical monitoring, quality control, clinic operations and site management. Chris leverages his extensive and diversified background daily to ensure that optimal customer service is achieved throughout the client relationship. 

Crystal Sounakhen hs.png

Crystal Sounakhen

Crystal Sounakhen, Senior Study Manager, has more than 10 years of research experience as a coordinator and study manager focused on Phase I studies in both healthy volunteers and patient populations. Crystal serves as one of the primary points of contact to ensure seamless communication and project oversight throughout study conduct.

Register here to watch on-demand!